In GSE168568 (n=205), IL4R and SLC9A8 showed significant upregulation in IBD patients compared to controls, while EIF5A did not reach statistical significance (FDR < 0.1), likely due to higher variability. Here, SLC9A8 is linked to inflammatory bowel disease.